Track the RITTER PHARMACEUTICALS INC stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). The latest transaction was disclosed on 11 January 2016 (Acquisition). Among the most active insiders: FOEHR MATTHEW W. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
RITTER PHARMACEUTICALS INC is a company focused on developing treatments for gastrointestinal diseases. It is listed on NASDAQ under the ticker RITT.